The pandemic had an adverse impact on sales in the third quarter of about $700 million to $750 million though sales rose in the U.S.
“We anticipate that profitability and sales growth may be hard to come by for the foreseeable future,” an analyst says of the drugstore chain.
The success or failure of these 20 CFOs will decide their companies’ futures in a time of economic uncertainty and technological disruption.
“Following a difficult second quarter, we made progress in the third quarter against the strategic goals we set," CEO Stefano Pessina says.
Univision, Walgreens, UGI, Lubrizol, Sequential Brands, Infoblox, Maxar Technologies, West Pharmaceutical Services, FormFactor, Career Education
